Therapeutic strategies to alter the oxygen affinity of sickle hemoglobin.
about
Anemia: progress in molecular mechanisms and therapiesIdentification of a Small Molecule that Increases Hemoglobin Oxygen Affinity and Reduces SS Erythrocyte SicklingGBT440 increases haemoglobin oxygen affinity, reduces sickling and prolongs RBC half-life in a murine model of sickle cell diseaseAryloxyalkanoic Acids as Non-Covalent Modifiers of the Allosteric Properties of HemoglobinKinetic assay shows that increasing red cell volume could be a treatment for sickle cell disease.Identification of a novel class of covalent modifiers of hemoglobin as potential antisickling agentsCation Homeostasis in Red Cells From Patients With Sickle Cell Disease Heterologous for HbS and HbC (HbSC Genotype).Fetal Hemoglobin is Associated with Peripheral Oxygen Saturation in Sickle Cell Disease in Tanzania.Cardioprotective effects of 5-hydroxymethylfurfural mediated by inhibition of L-type Ca(2+) current.Should modulation of p50 be a therapeutic target in the critically ill?Design, Synthesis, and Biological Evaluation of Ester and Ether Derivatives of Antisickling Agent 5-HMF for the Treatment of Sickle Cell Disease.Rational design of pyridyl derivatives of vanillin for the treatment of sickle cell disease.A Triazole Disulfide Compound Increases the Affinity of Hemoglobin for Oxygen and Reduces the Sickling of Human Sickle Cells.Prospects for early investigational therapies for sickle cell disease.Development and validation of an oxygen dissociation assay, a screening platform for discovering, and characterizing hemoglobin-oxygen affinity modifiers.
P2860
Q27023172-82CB6185-7D79-4867-9B64-3689A33F7534Q27684817-91032534-587E-45BE-8E6D-BC2E5EF03577Q27716374-BDFF78F5-4758-4A71-83F1-AB306B4107B7Q27727697-CF3EC37E-F419-4AF9-B4B3-39B1A2E1BA8EQ30837666-6213803F-E182-417D-AA83-D00054318023Q35661138-B0E95752-E786-44C7-BED6-F202692E9EB0Q36540959-4A368D2C-F063-4511-9753-57C7412FE356Q38606802-2E2EC44D-03D3-433D-BB09-17975EBE0AA9Q38646543-5775A96D-DBAE-405A-BBC7-B0CA092D481EQ39237387-AAE729C5-3C16-4862-A649-D8CD96014E28Q45066332-5BE10538-DF73-4527-A410-640C2DFC791FQ52321402-4FF4217C-2CE4-4532-AE98-5A575A254306Q52596367-6EF2578A-749D-4E75-8D01-CCC96508225FQ53608275-6AD70C95-074D-44F8-8C98-B145740D0E9FQ55318498-EF47417F-0052-499A-AEB8-5E615A5FC703
P2860
Therapeutic strategies to alter the oxygen affinity of sickle hemoglobin.
description
2014 nî lūn-bûn
@nan
2014 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Therapeutic strategies to alter the oxygen affinity of sickle hemoglobin.
@ast
Therapeutic strategies to alter the oxygen affinity of sickle hemoglobin.
@en
Therapeutic strategies to alter the oxygen affinity of sickle hemoglobin.
@nl
type
label
Therapeutic strategies to alter the oxygen affinity of sickle hemoglobin.
@ast
Therapeutic strategies to alter the oxygen affinity of sickle hemoglobin.
@en
Therapeutic strategies to alter the oxygen affinity of sickle hemoglobin.
@nl
prefLabel
Therapeutic strategies to alter the oxygen affinity of sickle hemoglobin.
@ast
Therapeutic strategies to alter the oxygen affinity of sickle hemoglobin.
@en
Therapeutic strategies to alter the oxygen affinity of sickle hemoglobin.
@nl
P2860
P1476
Therapeutic strategies to alter the oxygen affinity of sickle hemoglobin.
@en
P2093
Martin K Safo
P2860
P304
P356
10.1016/J.HOC.2013.11.001
P577
2014-01-21T00:00:00Z